Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MHLJDD for Atopic Dermatitis in Children
NCT05613062Phase 2Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Apr 2023
- Primary completion
- Aug 2024
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Modified Huang-Lian-Jie-Du Decoction in atopic dermatitis (AD) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Eczema Area and Severity Index at 12 weeks. Started Apr 2023; status: completed.
02
Drugs
Modified Huang-Lian-Jie-Du Decoction
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT05613062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05613062.